Cargando…
Cisplatin and Beyond: Molecular Mechanisms of Action and Drug Resistance Development in Cancer Chemotherapy
BACKGROUND: Platinum-based anticancer drugs are widely used in the chemotherapy of human neoplasms. The major obstacle for the clinical use of this class of drugs is the development of resistance and toxicity. It is therefore very important to understand the chemical properties, transport and metabo...
Autor principal: | Makovec, Tomaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572495/ https://www.ncbi.nlm.nih.gov/pubmed/30956230 http://dx.doi.org/10.2478/raon-2019-0018 |
Ejemplares similares
-
Molecular mechanisms of cisplatin resistance in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016) -
Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy
por: Tchounwou, Paul B, et al.
Publicado: (2021) -
Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond
por: Al Bitar, Samar, et al.
Publicado: (2023) -
The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer
por: O'Byrne, Kenneth J., et al.
Publicado: (2011) -
Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer Chemotherapy
por: Chen, Helen H. W., et al.
Publicado: (2010)